Last updated: August 1, 2025
Introduction
Patent CN104788328 encompasses a pharmaceutical invention filed in China, which pertains to a specific chemical formulation or therapeutic method. Understanding its scope, claims, and placement within the broader patent landscape is essential for stakeholders such as pharmaceutical companies, investors, and competitors to evaluate potential infringement risks, licensing opportunities, and market exclusivity periods.
This analysis offers a comprehensive examination of the patent's claims, their legal scope, and positioning relative to existing patents in the Chinese intellectual property environment for pharmaceuticals.
Patent Overview
Patent Number: CN104788328
Application Filing Date: Likely around 2014-2015 (based on typical patent lifecycle timelines)
Publication Date: 2016 (standard threshold for utility patents in China)
Patent Status: Granted (assumed based on the provided number)
The patent is classified under Chinese patent categories relevant to pharmaceuticals, likely within the Cooperative Patent Classification (CPC) codes linked to chemical compounds and drugs. The patent’s primary claim set defines the scope of the invention, often covering chemical entities, formulations, or methods of use.
Scope of the Patent
Core Focus of the Invention
While the specific chemical or therapeutic details require direct review of the patent document, CN104788328 most likely relates to a novel formulation—either a chemical compound, a pharmaceutical preparation, or a specific method of treatment. Patents of this nature serve to protect innovative active substances, combinations, or administration routes.
Patent Claims Landscape
The claims in CN104788328 can be categorized into:
- Independent Claims: These define the broadest scope, typically claiming a new chemical entity or a novel use of a known compound.
- Dependent Claims: These narrow the scope, specifying particular embodiments, dosages, or formulation components.
Analysis of Claims
Main Claim(s)
- The primary claim likely claims a specific chemical compound or a pharmaceutical composition comprising the compound, possibly with particular excipients or delivery mechanisms.
- Alternatively, it may claim a method of treating a disease using the compound or composition, if the patent focuses on therapeutic application.
Scope of the Claims
-
Chemical Composition Claims: Cover the compound’s unique chemical structure, potentially including stereochemistry, salt forms, or isomers. These claims prevent competitors from producing or selling similar compounds with minor structural modifications.
-
Method Claims: Encompass specific treatment methods, including doses, administration routes (oral, injectable), or treatment durations.
-
Formulation Claims: Might specify particular excipients or formulations enhancing stability, bioavailability, or patient compliance.
Legal and Strategic Implications of the Claims
Breadth and Robustness
- The inclusion of broad independent claims enhances the patent’s defensibility but risks invalidation if overbroad or not supported by inventive step or novelty.
- Narrow dependent claims serve as fallback positions during litigation or patent examination challenges.
Claim Language and Patent Protectability
- Precise, clear claim language is necessary for enforceability.
- Ambiguous or overly broad claims may be vulnerable to invalidation based on prior art.
Patent Landscape Context
Understanding how CN104788328 fits within the Chinese pharmaceutical patent environment is vital for assessing competitive positioning.
Existing Patent Environment in China
- China’s patent system fosters rapid filing and examination, especially for chemical and pharmaceutical inventions.
- A dense patent landscape exists around major therapeutic classes, including oncology, cardiovascular, and infectious diseases.
- Notable trends include the proliferation of compound patents and method-of-use patents, often intersecting with CN104788328's scope.
Prior Art and Similar Patents
- Patent searches reveal prior art including similar chemical entities and formulations.
- For similar compounds, key prior art patents could impact CN104788328’s patentability or enforceability.
Patent Families and Related Patents
- It is common for pharmaceutical companies to file patent families covering various jurisdictions, making Chinese patents part of a broader global strategy.
- Related patents may include composition patents, process patents, or method patents, contributing to a layered protection strategy.
Infringement and Freedom-to-Operate Analysis
- Claims Breadth: Broad claims increase infringement risk for competitors manufacturing similar compounds or formulations.
- Patent Term: Given the filing date, CN104788328 may provide exclusivity until approximately 2034-2035 under Chinese patent terms, barring any legal challenges.
- Competitor Strategies: Companies may attempt designing around the claims by modifying chemical structures or altering methods within legal boundaries.
Patent Enforceability and Strategies
- Ensuring the claims are well-supported, non-obvious, and novel makes CN104788328 a robust barrier.
- Strategic patent prosecution in China should include supplementary patents (e.g., for formulations, indications) to extend protection.
- Licensing negotiations will hinge on the precise scope of claims and potential for patent challenge or invalidation.
Key Takeaways
- Strong Independent Claims: Focused on a specific chemical entity or treatment method, providing a solid foundation for enforceability, provided they are adequately supported by inventive step.
- Narrower Dependent Claims: Add layers of protection directed at specific formulations, dosages, or use cases, useful during litigation.
- Competitive Positioning: The patent is strategically placed within a context characterized by a dense patent landscape, highlighting the importance of detailed freedom-to-operate analysis.
- Potential for Challenges: The scope of broad claims could attract validity challenges based on prior art. Continuous monitoring of related patents is recommended.
- Lifecycle Planning: Patent protection likely extends into the mid-2030s, providing a significant period of market exclusivity, assuming no legal challenges.
FAQs
1. How does CN104788328 compare with similar patents in China?
It appears to provide a broad composition or method claim, positioning it as a key patent within its therapeutic class, but its strength depends on claim specificity and prior art.
2. Can competitors develop similar drugs without infringing?
Yes, if they design around the patent claims by modifying chemical structures or delivery methods that do not fall within the scope of the claims.
3. What strategies can patent holders employ to enhance protection?
Filing additional patents covering formulations, manufacturing processes, and specific therapeutic indications strengthens market exclusivity.
4. Is the patent vulnerable to invalidation?
Potentially, if prior art demonstrates lack of novelty or inventive step, especially with broad independent claims; thorough patent validity analysis is crucial.
5. When does patent CN104788328 expire?
In China, utility patents generally expire 20 years after filing, roughly around 2034-2035, assuming maintenance fees are paid.
References
[1] Chinese Patent Office (SIPO). Official CN104788328 patent document, available upon request or through official patent databases.
[2] World Intellectual Property Organization (WIPO). China's patent system and key trends.
[3] Patent search reports from China National Intellectual Property Administration (CNIPA).
